Matches in SemOpenAlex for { <https://semopenalex.org/work/W63236448> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W63236448 endingPage "7, 255" @default.
- W63236448 startingPage "222" @default.
- W63236448 abstract "Oral contraceptives have been used for many years and a number of adverse effects have been recognized (e.g., jaundice, deep vein thrombosis, thromboembilic disease, gallbladder disease, breast carcinoma, endometrial carcinoma and photosensitivity). Tumour-like lesions of the liver have also been reported. The presentation of such tumours, their management and pathologic features are reviewed. The biochemical effects of the oral contraceptive on the liver, with particular reference to jaundice, are discussed in detail.This paper discusses the hepatic and biochemical effects of OCs (oral contraceptives) based on a review of current literature on the subject. The histological and pathologic features of liver tumors are described, as are the different etiological agents (diethylstilbestrol and androgenic anabolic steroids) and methods used in the management of liver tumors (laparotomy; normal tissue excision; liver scanning and ultrasonography; clinical surveillance; further pregnancies are not recommended). Estrogens and progesterones were found not to be highly cytolitic to liver cells, with estrogen being more cholestatic than progesterone. When given alone, neither is capable of producing high transaminasemia. When progestogens are given simultaneously, the cholestatic effect of estrogens is enhanced. Contraindications to OC use are cholestasis of pregnancy; constitutional hyperbilirubinemia; primary biliary cirrhosis within 6 months after infectious hepatitis and preexisting chronic liver disease. Development of jaundice or an increase in serum glutamic pyruvic transaminase concentration and retention of bromsulfalein are not considered contraindications to OC use. The lowest possible dose of estrogens should be used to achieve contraceptive effect. During the 1st 2 months of OC use, the pill user should have her blood tested for bilirubin weekly. Darkening of urine necessitates further examination. Possibility of liver tumors in pill users should be considered. Any fertile-aged OC user may experience spontaneous rupture of liver with evidence of hemoperitoneum. Benign tumor as a cause of hemoperitoneum should be excised together with the smallest amount of normal liver tissue necessary to achieve hemostasis." @default.
- W63236448 created "2016-06-24" @default.
- W63236448 creator A5035064051 @default.
- W63236448 date "1980-05-01" @default.
- W63236448 modified "2023-09-23" @default.
- W63236448 title "Liver and the contraceptive pill." @default.
- W63236448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6247051" @default.
- W63236448 hasPublicationYear "1980" @default.
- W63236448 type Work @default.
- W63236448 sameAs 63236448 @default.
- W63236448 citedByCount "3" @default.
- W63236448 crossrefType "journal-article" @default.
- W63236448 hasAuthorship W63236448A5035064051 @default.
- W63236448 hasConcept C126322002 @default.
- W63236448 hasConcept C2777075537 @default.
- W63236448 hasConcept C2777164284 @default.
- W63236448 hasConcept C2777214474 @default.
- W63236448 hasConcept C2778456037 @default.
- W63236448 hasConcept C2778593092 @default.
- W63236448 hasConcept C2779102576 @default.
- W63236448 hasConcept C2780965833 @default.
- W63236448 hasConcept C512861765 @default.
- W63236448 hasConcept C71924100 @default.
- W63236448 hasConcept C90924648 @default.
- W63236448 hasConceptScore W63236448C126322002 @default.
- W63236448 hasConceptScore W63236448C2777075537 @default.
- W63236448 hasConceptScore W63236448C2777164284 @default.
- W63236448 hasConceptScore W63236448C2777214474 @default.
- W63236448 hasConceptScore W63236448C2778456037 @default.
- W63236448 hasConceptScore W63236448C2778593092 @default.
- W63236448 hasConceptScore W63236448C2779102576 @default.
- W63236448 hasConceptScore W63236448C2780965833 @default.
- W63236448 hasConceptScore W63236448C512861765 @default.
- W63236448 hasConceptScore W63236448C71924100 @default.
- W63236448 hasConceptScore W63236448C90924648 @default.
- W63236448 hasIssue "3" @default.
- W63236448 hasLocation W632364481 @default.
- W63236448 hasOpenAccess W63236448 @default.
- W63236448 hasPrimaryLocation W632364481 @default.
- W63236448 hasRelatedWork W182289028 @default.
- W63236448 hasRelatedWork W2018209381 @default.
- W63236448 hasRelatedWork W2035137798 @default.
- W63236448 hasRelatedWork W2151238595 @default.
- W63236448 hasRelatedWork W2350383809 @default.
- W63236448 hasRelatedWork W2413696976 @default.
- W63236448 hasRelatedWork W2414848196 @default.
- W63236448 hasRelatedWork W2417254063 @default.
- W63236448 hasRelatedWork W2418646045 @default.
- W63236448 hasRelatedWork W51976641 @default.
- W63236448 hasVolume "23" @default.
- W63236448 isParatext "false" @default.
- W63236448 isRetracted "false" @default.
- W63236448 magId "63236448" @default.
- W63236448 workType "article" @default.